Literature DB >> 32271649

Inequality in measles vaccination coverage in the "big six" countries of the WHO South-East Asia region.

Yaqing Gao1, Ashish Kc2, Chunyi Chen1, Yue Huang1, Yinping Wang1, Siyu Zou1, Hong Zhou1.   

Abstract

The "big six" countries (Bangladesh, India, Indonesia, Myanmar, Nepal, and Thailand) in the World Health Organization South-East Asia Region (WHO SEAR) are currently facing severe challenges in measles elimination and consequent childhood mortality reduction, with inadequacies and inequalities in the coverage of the measles-containing-vaccine first-dose (MCV1) being major obstacles. However, these issues of inequality in MCV1 coverage have not yet been systematically examined. We used data from the latest Demographic and Health Surveys and Multiple Indicator Cluster Surveys. To provide a comprehensive picture of existing MCV1 coverage gaps, data were disaggregated by geographic location, as well as by socioeconomic and nutritional dimensions. National MCV1 coverage ranged from 77% in Myanmar to 92% in Thailand. Only nine of the 104 sub-national districts had achieved the 95% MCV1 coverage goal as set by the WHO. Geographic inequalities were more pronounced in countries with lower coverage levels. Areas in clusters with poor MCV1 coverage performances as well as disadvantaged socioeconomic profiles require increased attention. Inequalities were evident in all countries, except Thailand, and were more pronounced in the sectors of wealth, education, antenatal care (ANC) status, and vitamin A supplementation (VAS) when compared against the areas of gender and urban/rural residence. Wealth-related inequality in Bangladesh, education-related inequality in Indonesia, ANC-related inequalities in Myanmar and Nepal, and VAS-related inequalities in Indonesia and Myanmar were all noteworthy. Equity-oriented changes in policies focusing on health promotion and integrated interventions among disadvantaged populations need to be implemented in order to increase MCV1 coverage and reduce childhood mortality.

Entities:  

Keywords:  Southeast Asia; child health; equity; measles; vaccines

Year:  2020        PMID: 32271649      PMCID: PMC7482855          DOI: 10.1080/21645515.2020.1736450

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  27 in total

1.  Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.

Authors:  C S Benn; P Aaby; C Balé; J Olsen; K F Michaelsen; E George; H Whittle
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

2.  Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries.

Authors:  Catherine Arsenault; Sam Harper; Arijit Nandi; José M Mendoza Rodríguez; Peter M Hansen; Mira Johri
Journal:  Vaccine       Date:  2017-01-06       Impact factor: 3.641

3.  Wasting is associated with stunting in early childhood.

Authors:  Stephanie A Richard; Robert E Black; Robert H Gilman; Richard L Guerrant; Gagandeep Kang; Claudio F Lanata; Kåre Mølbak; Zeba A Rasmussen; R Bradley Sack; Palle Valentiner-Branth; William Checkley
Journal:  J Nutr       Date:  2012-05-23       Impact factor: 4.798

Review 4.  Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review.

Authors:  Tim Crocker-Buque; Michael Edelstein; Sandra Mounier-Jack
Journal:  J Epidemiol Community Health       Date:  2016-08-17       Impact factor: 3.710

5.  An equity dashboard to monitor vaccination coverage.

Authors:  Catherine Arsenault; Sam Harper; Arijit Nandi; José M Mendoza Rodríguez; Peter M Hansen; Mira Johri
Journal:  Bull World Health Organ       Date:  2016-11-21       Impact factor: 9.408

6.  Effect and cost-effectiveness of educating mothers about childhood DPT vaccination on immunisation uptake, knowledge, and perceptions in Uttar Pradesh, India: A randomised controlled trial.

Authors:  Timothy Powell-Jackson; Camilla Fabbri; Varun Dutt; Sarah Tougher; Kultar Singh
Journal:  PLoS Med       Date:  2018-03-06       Impact factor: 11.069

7.  Analysis of State-Specific Differences in Childhood Vaccination Coverage in Rural India.

Authors:  Nijika Shrivastwa; Abram L Wagner; Matthew L Boulton
Journal:  Vaccines (Basel)       Date:  2019-02-24

Review 8.  Measuring coverage in MNCH: determining and interpreting inequalities in coverage of maternal, newborn, and child health interventions.

Authors:  Aluísio J D Barros; Cesar G Victora
Journal:  PLoS Med       Date:  2013-05-07       Impact factor: 11.069

9.  Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa.

Authors:  Tenley K Brownwright; Zan M Dodson; Willem G van Panhuis
Journal:  BMC Public Health       Date:  2017-12-15       Impact factor: 3.295

10.  Comparison of US County-Level Public Health Performance Rankings With County Cluster and National Rankings: Assessment Based on Prevalence Rates of Smoking and Obesity and Motor Vehicle Crash Death Rates.

Authors:  Megan Wallace; Joshua M Sharfstein; Joshua Kaminsky; Justin Lessler
Journal:  JAMA Netw Open       Date:  2019-01-04
View more
  3 in total

1.  Development and validation of the knowledge and attitude regarding childhood vaccination (KACV) questionnaire among healthcare workers: the Malay version.

Authors:  Azidah Abdul Kadir; Norhayati Mohd Noor; Ahmad Faiq Mukhtar
Journal:  Hum Vaccin Immunother       Date:  2021-10-29       Impact factor: 3.452

2.  Vaccine equity in low and middle income countries: a systematic review and meta-analysis.

Authors:  Huda Ahmed Ali; Anna-Maria Hartner; Susy Echeverria-Londono; Jeremy Roth; Xiang Li; Kaja Abbas; Allison Portnoy; Emilia Vynnycky; Kim Woodruff; Neil M Ferguson; Jaspreet Toor; Katy Am Gaythorpe
Journal:  Int J Equity Health       Date:  2022-06-11

3.  Evaluation of measles vaccination coverage in Lincang City, Yunnan Province, China.

Authors:  Xiaotong Yang; Tingting Tang; Zhikang Yang; Lu Liu; Shuyi Yuan; Tai Zhang
Journal:  Hum Vaccin Immunother       Date:  2021-04-13       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.